| Financial Year |
March 31 2023 |
| Monetary Funds |
7,384,460,615.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,008,059.20 |
| Accounts Receivable |
175,816,775.64 |
| Advances to Suppliers |
3,917,028,853.68 |
| Other Receivables |
108,797,788.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
209,125.71 |
| Inventories |
12,786,170,845.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
852,974,984.38 |
| Total Current Assets |
25,230,257,922.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,338,393,914.94 |
| Investment Properties |
3,891,669,138.74 |
| Fixed Assetes |
734,097,275.29 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,934,910.82 |
| R&D expenses |
-- |
| Goodwill |
40,456,329.28 |
| Long-Term Deferred and Prepaid Expenses |
2,622,500.15 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
10,389,786,863.41 |
| Total Assets |
35,620,044,786.32 |
| Short-Term Loans |
1,908,365,221.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,254,927,683.72 |
| Accounts Received In Advance |
24,178,448.90 |
| Employee Compensation Payable |
43,311,938.86 |
| Taxes Payable |
1,321,280,750.30 |
| Interest Payable |
53,977,694.46 |
| Dividend Payable |
-- |
| Other payables |
1,593,436,368.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,518,886,105.67 |
| Other Current Liabilities |
432,927,537.05 |
| Sub-Total of Current Liabilities |
15,411,615,134.91 |
| Long-term Loans |
7,553,850,000.00 |
| Bonds Payable |
889,048,693.56 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
396,309,967.08 |
| Deferred Income Tax Liabilities |
53,810,662.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,901,294,096.33 |
| Total Liabilities |
24,312,909,231.24 |
| Paid-In Capital(Or Share Stock) |
1,844,562,892.00 |
| Capital Surplus |
2,600,488,658.01 |
| Surplus Reserve |
565,611,289.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,282,501,304.63 |
| Minority Stockholder's Interest |
1,034,806,799.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,272,328,755.29 |
| Owner's Equity（Stockholder's Equity） |
11,307,135,555.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
35,620,044,786.32 |
